These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8093885

  • 41. Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study.
    Karaiskos D, Pappa D, Tzavellas E, Siarkos K, Katirtzoglou E, Papadimitriou GN, Politis A.
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):100-5. PubMed ID: 22431439
    [Abstract] [Full Text] [Related]

  • 42. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM.
    J Clin Psychiatry; 1996 Jan; 57 Suppl 2():10-4. PubMed ID: 8626357
    [Abstract] [Full Text] [Related]

  • 43. The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.
    Zhu B, Zhao Z, Ye W, Marciniak MD, Swindle R.
    J Nerv Ment Dis; 2009 Feb; 197(2):136-9. PubMed ID: 19214050
    [Abstract] [Full Text] [Related]

  • 44. Drug treatment of anxiety and depression.
    Fox T.
    Practitioner; 1991 Sep; 235(1506):681-3. PubMed ID: 1796034
    [No Abstract] [Full Text] [Related]

  • 45. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety.
    Mussell M, Kroenke K, Spitzer RL, Williams JB, Herzog W, Löwe B.
    J Psychosom Res; 2008 Jun; 64(6):605-12. PubMed ID: 18501261
    [Abstract] [Full Text] [Related]

  • 46. Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: the GADIS II study (Generalized Anxiety and Depression Impact Survey II).
    Ansseau M, Fischler B, Dierick M, Albert A, Leyman S, Mignon A.
    Depress Anxiety; 2008 Jun; 25(6):506-13. PubMed ID: 17595015
    [Abstract] [Full Text] [Related]

  • 47. Treatment of anxious depression with intravenous infusions of a combination of drugs.
    Krebs-Roubicek E, Koebl J, Poeldinger W.
    Agressologie; 1981 Nov; 22(D):25-6. PubMed ID: 6120664
    [No Abstract] [Full Text] [Related]

  • 48. Azapirones for generalized anxiety disorder.
    Chessick CA, Allen MH, Thase M, Batista Miralha da Cunha AB, Kapczinski FF, de Lima MS, dos Santos Souza JJ.
    Cochrane Database Syst Rev; 2006 Jul 19; 2006(3):CD006115. PubMed ID: 16856115
    [Abstract] [Full Text] [Related]

  • 49. The clinical course and long-term management of generalized anxiety disorder.
    Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1990 Jun 19; 10(3 Suppl):101S-110S. PubMed ID: 1973934
    [Abstract] [Full Text] [Related]

  • 50. Generalized anxiety disorder: new concepts and psychopharmacologic therapies.
    Dubovsky SL.
    J Clin Psychiatry; 1990 Jan 19; 51 Suppl():3-10. PubMed ID: 1967248
    [Abstract] [Full Text] [Related]

  • 51. Recognition of depressive syndromes, tricyclics, and the second generation antidepressants.
    Tollefson G, Tuason VB.
    Minn Med; 1984 Jun 19; 67(6):345-50. PubMed ID: 6147748
    [No Abstract] [Full Text] [Related]

  • 52. The drug treatment of anxiety and depression.
    Cole JO.
    Med Clin North Am; 1988 Jul 19; 72(4):815-30. PubMed ID: 3287039
    [Abstract] [Full Text] [Related]

  • 53. New findings in anxiety. A synthesis for clinical practice in 1985.
    Curtis GC.
    Psychiatr Clin North Am; 1985 Mar 19; 8(1):169-75. PubMed ID: 2859578
    [Abstract] [Full Text] [Related]

  • 54. [Differential diagnosis of anxiety states and depressive syndromes].
    Verhoeven WM.
    Acta Psychiatr Belg; 1984 Mar 19; 84():533-40. PubMed ID: 6528820
    [Abstract] [Full Text] [Related]

  • 55. [Therapy with antidepressive and tranquilizing agents].
    Barocka A.
    Fortschr Med; 1984 Aug 30; 102(31-32):775-9. PubMed ID: 6148296
    [Abstract] [Full Text] [Related]

  • 56. Management of anxiety and depression syndromes in the elderly.
    Weiss KJ.
    J Clin Psychiatry; 1994 Feb 30; 55 Suppl():5-12. PubMed ID: 7915714
    [Abstract] [Full Text] [Related]

  • 57. The use of psychotropic drugs in the treatment of compulsive opiate abusers: the rationale for their use.
    Kleber HD.
    Adv Alcohol Subst Abuse; 1994 Feb 30; 5(1-2):103-19. PubMed ID: 2870623
    [Abstract] [Full Text] [Related]

  • 58. Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression.
    Schmauss M, Laakmann G, Dieterle D.
    J Clin Psychopharmacol; 1988 Apr 30; 8(2):108-11. PubMed ID: 3372705
    [Abstract] [Full Text] [Related]

  • 59. A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
    Akiskal HS.
    J Clin Psychiatry; 1985 Oct 30; 46(10 Pt 2):32-7. PubMed ID: 3930475
    [Abstract] [Full Text] [Related]

  • 60. Refractory generalized anxiety disorder.
    Pollack MH.
    J Clin Psychiatry; 2009 Oct 30; 70 Suppl 2():32-8. PubMed ID: 19371505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.